GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,335.50GBp
6:05am EDT
Change (% chg)

2.50p (+0.19%)
Prev Close
1,333.00p
Open
1,339.00p
Day's High
1,344.50p
Day's Low
1,329.00p
Volume
1,974,262
Avg. Vol
9,361,664
52-wk High
1,645.00p
52-wk Low
1,296.50p

GSK.L

Chart for GSK.L

About

GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic... (more)

Overall

Beta: 0.60
Market Cap(Mil.): £64,868.97
Shares Outstanding(Mil.): 4,866.39
Dividend: 19.00
Yield (%): 6.00

Financials

  GSK.L Industry Sector
P/E (TTM): 6.32 36.91 40.75
EPS (TTM): 2.11 -- --
ROI: 31.01 16.39 15.62
ROE: 144.87 17.22 16.71
Search Stocks

UPDATE 3-World's first malaria vaccine gets regulatory go-ahead, faces WHO review

* WHO to assess vaccine in October before possible rollout (Adds WHO giving date for its review, WHO quotes)

24 Jul 2015

CORRECTED-UPDATE 1-World's first malaria vaccine gets go-ahead from EU regulators

LONDON, July 24 - The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it as safe and effective to use in babies in Africa at risk of the mosquito-borne disease.

24 Jul 2015

BRIEF-Glaxosmithkline malaria vaccine Mosquirix gets EMA nod

* GSK's malaria candidate vaccine, mosquirixtm (rts,s), receives positive opinion from european regulators for prevention of malaria Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

24 Jul 2015

China state guesthouse sues Philips, claims fake ads and demands apology

SHANGHAI, July 21 - A Chinese central government guesthouse, where Beijing has hosted leaders from Nixon to Putin, has sued electronics maker Koninklijke Philips NV claiming false advertising, a potential headache for the Dutch firm in one of its key markets.

21 Jul 2015

Britain's FTSE led lower by M&S, GlaxoSmithKline

LONDON, July 17 - Britain's top shares edged slightly lower on Friday, lagging euro zone stocks, with retailer Marks & Spencer leading the falls after announcing the departure of its clothing boss.

17 Jul 2015

UPDATE 1-India expands medicine price control list to include 39 more drugs

* Abbott, GSK, Lupin and Ipca among firms affected (Adds details on government's position, results of new study )

16 Jul 2015

GSK first drugmaker to tie up with new Crick institute

LONDON - GlaxoSmithKline said on Tuesday it had forged a collaboration with the Francis Crick Institute, making it the first pharmaceutical company to link up with the new biomedical center based in London.

13 Jul 2015

GSK first drugmaker to tie up with new Crick institute

LONDON, July 14 - GlaxoSmithKline said on Tuesday it had forged a collaboration with the Francis Crick Institute, making it the first pharmaceutical company to link up with the new biomedical centre based in London.

13 Jul 2015

GlaxoSmithKline seeks MDL for Zofran birth-defect cases

- GlaxoSmithKline has asked a federal judicial panel to consolidate a dozen lawsuits alleging that its anti-nausea medication Zofran can cause birth defects in children born to women who took the drug while pregnant.

07 Jul 2015

Manufacturing deal wins China cheap supply of GSK's new HIV drug

LONDON - China will receive cut-price supplies of GlaxoSmithKline's new HIV drug Tivicay, following a deal for Shanghai-based Desano Pharmaceuticals to become an additional manufacturer of the medicine's active ingredient.

02 Jul 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks